Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2012

View Archived Issues

New human cellular models of Alzheimer's disease developed

Scientists link new genes to Baraitser-Winter syndrome

In vitro results show potency of novel bispecific HIV-1-neutralizing antibody

OPKO Health attains global license to novel Parkinson's disease candidate

Anthera Pharmaceuticals stops VISTA-16 study

Further data reported on add-on boceprevir therapy in HCV/HIV-coinfected patients

Cellceutix files pre-IND submission for candidate psoriasis drug

Intrepid to conduct phase II trial of candidate acne treatment

MediGene announces additional approvals of topical drug for genital warts

Watson Pharmaceuticals launches new phase III trial

BrainStorm Cell Therapeutics plans stem cell trial in MS

Aradigm obtains clearance for phase III Pulmaquin study

Shionogi identifies new P2X3 and P2X2/3 receptor antagonists

New PI3K inhibitors developed

Novel potential neutropenia therapies developed

Merck & Co. announces new vaccines

Astellas Pharma discloses new inhibitors of IL-2 production and PI3Kdelta

Medivir launches two new phase III TMC-485 studies

Allon Therapeutics advances preclinical work in Parkinson's disease

Amorfix announces new technology acquisition

Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine

Tranzyme Pharma and Norgine report topline data on ulimorelin

Reviva Pharmaceuticals kicks off enrollment in phase II RP-5063 trial

DNDi launches phase I trial of drug for sleeping sickness

Phase II results trigger milestone payment to NicOx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...